Valued at USD 15.85 billion in 2025, the biosurgery market is projected to reach USD 16.85 billion in 2026 and USD 27.66 billion by 2034, growing at a CAGR of 6.38% during the forecast period 2026–2034, according to Polaris Market Research. North America led the market in 2025 with a 40.4% share. Leading companies include Artivion, Inc.; Aroa Biosurgery; B. Braun SE; Baxter; BD; INTEGRA LIFESCIENCES; Johnson & Johnson Services, Inc.; Medtronic; Pfizer Inc.; Sanofi; and Stryker.

Aging Population Reshapes Surgical Demand

The World Health Organization stated that by 2030, one in six people worldwide will be aged 60 years and above. An expanding aging population drives demand for joint replacements, wound care, and cancer surgeries, where hemostats, adhesives, and mesh grafts play a critical role in improving recovery and reducing complications. Slower healing in geriatric patients increases reliance on advanced biosurgery solutions, and older adults' growing preference for minimally invasive procedures further supports demand. In Europe, projected at a 5.89% CAGR by 2034, the rising aging population requires more orthopedic and soft tissue repair procedures.

Soft Tissue Attachments Track Orthopedic Growth

The soft tissue attachments segment is projected to grow at a CAGR of 6.02%. A surge in sports injuries propels demand for orthopedic reconstruction and soft tissue repair, while rising participation in physical activity and musculoskeletal disorders among older adults add momentum. Surgeons increasingly rely on suture anchors, fixation devices, and mesh systems to enhance stability and promote tissue regeneration, and innovation in bioresorbable materials and minimally invasive fixation techniques strengthens the segment's appeal. In January 2026, Royal Biologics signed an exclusive distribution agreement with Aroa Biosurgery for Myriad Matrix Restore, expanding access to soft tissue repair across outpatient and mobile care settings in the U.S.

Bone Graft Attachments and Adhesion Barriers

The product landscape of the biosurgery market also includes bone graft attachments and adhesion barriers, alongside sealants, hemostats, and soft tissue attachments. In January 2025, Kuros Biosciences USA signed an exclusive strategic agreement naming Medtronic's Spinal Division as sole sales agent for MagnetOs in specified territories for spinal surgery applications. Advanced technologies such as 3D-printed grafts and stem cell-based therapies are expanding the range of treatable conditions and encouraging healthcare providers to invest in biosurgery.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/biosurgery-market

AI-Enabled Surgical Planning and Digital Tools

Artificial intelligence is influencing the market in several ways. AI-enabled surgical planning tools improve precision and reduce procedural risks in biosurgery applications. Machine learning algorithms help boost biomaterial discovery and development, AI-powered imaging systems enhance real-time tissue analysis, and hospitals use predictive analytics to optimize inventory and resource management. AI-driven robotic surgery platforms further enhance accuracy in minimally invasive biosurgical procedures.

Biosurgery Market Regional Momentum

Asia Pacific is projected to register a 7.47% CAGR from 2026 to 2034 on improving healthcare infrastructure and rising surgical volumes, with China and Japan investing heavily in advanced medical technologies; Vietnam's healthcare expenditure was approximately USD 18.5 billion in 2022, or 4.6% of GDP. India is expanding at a CAGR of 8.34%, as trauma cases, road accidents, and chronic wounds create strong demand and medical tourism attracts international patients. In the US, which held an 81.8% share of North America, healthcare spending grew 7.5% in 2023 to USD 4.9 trillion, according to the American Medical Association.

Competitive Landscape and Constraints

Medtronic leads with extensive product lines, including advanced hemostats and sealants, while Stryker has advanced through acquisitions and specialized products for orthopedic and trauma surgeries. Competition centers on product portfolios, technological advancement, and strategic collaborations in wound management, hemostats, sealants, adhesion prevention, and soft tissue management. The high cost of biosurgery products and procedures, however, limits accessibility and adoption, especially in emerging regions.

More Trending Latest Reports By Polaris Market Research:

Gynecological Examination Chairs Market

Fluoropolymers Market

Safari Tourism Market

Enterprise Content Management Market

Automotive Ceramics Market

Mass Flow Controller Market

Hemophilia A Treatment Market

AI Trust, Risk and Security Management Market